The major component of Lewy Bodies (LB), the pathological hallmark of Parkinson's disease (PD) is α-synuclein, most prominently phosphorylated at serine 129. G-protein coupled receptor kinase 5 (GRK5) has been reported to phosphorylate α-synuclein in vitro, enhancing the α-synuclein toxicity to dopaminergic neurons in Drosophila model. Moreover, GRK5 was found in LBs from brain of PD patients. A genetic association study performed in the Japanese population revealed haplotypic association of the GRK5 gene with susceptibility to sporadic PD. We aimed at investigating whether four polymorphisms within the GRK5 gene (rs871196, rs2420616, rs7069375, rs4752293) could represent a risk factor for sporadic PD in Southern Italy. We genotyped 446 patients with PD and 450 controls for these markers and did not find any significant association with the disease at allelic, genotypic and haplotypic level. Our results indicate that the GRK5 gene does not confer risk to sporadic PD in our sample from Southern Italy.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1002/ajmg.b.31129 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Genetic Associations of Persistent Opioid Use After Surgery Point to OPRM1 but Not Other Opioid-Related Loci as the Main Driver of Opioid Use Disorder.
Genet Epidemiol
January 2025
Department of Anesthesiology, University of Michigan Medical School, Ann Arbor, Michigan, USA.
Article Synopsis
- Persistent opioid use after surgery increases the risk of opioid use disorder, overdose, and death, but the genetic factors behind this issue were largely unknown.
- A study with around 40,000 participants identified some genetic signals associated with persistent opioid use, particularly focusing on the OPRM1 gene, where two variants showed significant results.
- The findings strengthen the link between opioid dependence and addiction, but the lack of consistent associations in other genes questions the reliability of previous studies.
Irg1 regulates bone homeostasis via regulating the Grk5 expression.
Biochem Biophys Res Commun
November 2024
Department of Orthopaedic, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China; Key Laboratory of Musculoskeletal System Degeneration and Regeneration Translational Research of Zhejiang Province, Hangzhou, China; Key Laboratory of Biotherapy of Zhejiang Province, Hangzhou, China. Electronic address:
Article Synopsis
- * In experiments, osteoclast differentiation increased in bone marrow macrophages lacking Irg1, alongside enhanced expression of osteoclast-related genes and a notable increase in Grk5 expression.
- * Despite changes in cellular activity, Irg1 knockout mice did not show significant differences in bone structure or osteoclast numbers compared to normal mice, but exhibited higher levels of inflammatory factors, suggesting that the Irg1-Grk5 pathway could become a target for treating related diseases.
Multi-trait analysis reveals risk loci for heart failure and the shared genetic etiology with blood lipids, blood pressure, and blood glucose.
Cell Rep
September 2024
Cardiology Department, Dongfang Hospital, Beijing University of Chinese Medicine, Beijing, China. Electronic address:
Phenotypic associations have been reported between heart failure (HF) and blood lipids (BLs), blood pressure (BP), and blood glucose (BG). However, the shared genetic etiology underlying these associations remains incompletely understood. Conducting a large-scale multi-trait association study for HF with these traits, we discovered 143 previously unreported genomic risk loci for HF.
View Article and Find Full Text PDFClinical Pharmacogenetics Implementation Consortium Guideline (CPIC) for CYP2D6, ADRB1, ADRB2, ADRA2C, GRK4, and GRK5 Genotypes and Beta-Blocker Therapy.
Clin Pharmacol Ther
October 2024
Center for Individualized and Genomic Medicine Research (CIGMA), Henry Ford Hospital, Detroit, Michigan, USA.
Beta-blockers are widely used medications for a variety of indications, including heart failure, myocardial infarction, cardiac arrhythmias, and hypertension. Genetic variability in pharmacokinetic (e.g.
View Article and Find Full Text PDFPrevious studies have identified G protein-coupled receptor (GPCR) kinase 5 (GRK5) as a genetic factor contributing to obesity pathogenesis, but the underlying mechanism remains unclear. We demonstrate here that Grk5 mRNA is more abundant in stromal vascular fractions of mouse white adipose tissue, the fraction that contains adipose progenitor cells, or committed pre-adipocytes, than in adipocyte fractions. Thus, we generated a GRK5 knockout (KO) 3T3-L1 pre-adipocyte to further investigate the mechanistic role of GRK5 in regulating adipocyte differentiation.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!